298 related articles for article (PubMed ID: 16881976)
1. Sirolimus-eluting stent in chronic total occlusion: the SICTO study.
Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W
J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976
[TBL] [Abstract][Full Text] [Related]
2. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG
Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768
[TBL] [Abstract][Full Text] [Related]
3. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
4. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
[TBL] [Abstract][Full Text] [Related]
5. Angiographic and clinical outcome following sirolimus-eluting stent (Cypher) implantation. A single center experience.
Ozcan T; Cin VG; Yurtdas M; Akcay B; Seyis S; Acele A; Cicek D; Camsari A; Akkus N; Doven O
Int Heart J; 2007 Jan; 48(1):11-23. PubMed ID: 17379975
[TBL] [Abstract][Full Text] [Related]
6. Prospective native coronary artery stenosis treated with sirolimus-eluting stent (ONASSIS) registry--acute results and mid-term outcomes: a single-center experience.
Voudris V; Alexopoulos E; Karyofillis P; Malakos J; Manginas A; Spargias C; Pavlides G; Patsilinakos S; Anyfantakis A; Cokkinos DV
J Invasive Cardiol; 2005 Aug; 17(8):401-5. PubMed ID: 16079443
[TBL] [Abstract][Full Text] [Related]
7. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
[TBL] [Abstract][Full Text] [Related]
12. Primary stenting of occluded native coronary arteries II--rationale and design of the PRISON II study: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions.
Rahel BM; Laarman GJ; Suttorp MJ;
Am Heart J; 2005 Mar; 149(3):e1-3. PubMed ID: 15864219
[TBL] [Abstract][Full Text] [Related]
13. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
[TBL] [Abstract][Full Text] [Related]
14. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
[TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
[TBL] [Abstract][Full Text] [Related]
16. Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation.
Kaneda H; Ako J; Honda Y; Terashima M; Morino Y; Yock PG; Popma JJ; Leon MB; Moses JW; Fitzgerald PJ
Am J Cardiol; 2005 Nov; 96(10):1404-7. PubMed ID: 16275187
[TBL] [Abstract][Full Text] [Related]
17. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
[TBL] [Abstract][Full Text] [Related]
19. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions.
Nakamura S; Muthusamy TS; Bae JH; Cahyadi YH; Udayachalerm W; Tresukosol D
Am J Cardiol; 2005 Jan; 95(2):161-6. PubMed ID: 15642545
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
